Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04670627 · ClinicalTrials.gov registry record
Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics
A clinical trial of Seasonal Allergic Rhinitis and Rhinovirus, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 92
- Enrollment target
- 1
- Study location
NCT04670627 is a study of Seasonal Allergic Rhinitis and Rhinovirus that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 92 participants, below the 662-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04670627, a study of Seasonal Allergic Rhinitis and Rhinovirus, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to analyze nasal samples for the presence of biomarkers of allergic inflammation as well as cold and flu infections, and compare these samples both in and out of an individual's active allergy season. 40 subjects who suffer from seasonal allergies will be recruited and seen both in and out of allergy season, and 10 healthy controls. Nasal epithelial lining fluid (NELF,) collected by placing small filter papers into the nostrils, blood for analysis and a cold/flu swab will be collected at each study visit.
Conditions Studied
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2021-03-22 |
| Est. Completion | 2023-04-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04670627
The ClinicalTrials.gov registry entry for NCT04670627 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 662-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target (86% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Seasonal Allergic Rhinitis appearing as the primary indexed condition, and to 0 interventions.
NCT04670627 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04670627 about?
NCT04670627 is a clinical study titled "Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics". The purpose of this study is to analyze nasal samples for the presence of biomarkers of allergic inflammation as well as cold and flu infections, and compare these samples both in and out of an individual's active allergy season. 40 subjects who suffer from seasonal allergies will be recruited and s...
What is the current status of trial NCT04670627?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2021-03-22. Estimated completion is 2023-04-27.
What conditions does trial NCT04670627 study?
This clinical trial studies the following conditions: Seasonal Allergic Rhinitis, Rhinovirus.
Who is sponsoring clinical trial NCT04670627?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04670627 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Seasonal Allergic Rhinitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)
COMPLETED · Phase 3
-
Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)
COMPLETED · Phase 3
-
Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™
COMPLETED · Phase 2
-
Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial
COMPLETED · Phase 4
-
A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
COMPLETED · Phase 3
-
Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit
COMPLETED · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.